The Visions PV .014P RX digital IVUS catheter has a 55% stiffer shaft than Eagle Eye Platinum and PV .014P digital IVUS catheters to facilitate greater pushability while preserving the equivalent level of trackability.¹ IVUS provides detailed and accurate assessment of lumen size, vessel size, plaque morphology and key anatomical landmarks.
Genom att klicka på länken kommer du att lämna den officiella Philips Electronics Ltd. ("Philips") webbplats. Alla länkar till tredje parts webbplatser som kan visas på denna webbplats tillhandahålls endast för din bekvämlighet och representerar inte på något sätt någon anknytning till eller stöd för informationen som tillhandahålls på dessa länkade webbplatser. Philips lämnar inga utfästelser eller garantier av något slag med avseende på tredje parts webbplatser eller informationen däri.
For immediate technical support, please use the phone number below.
Philips Sweden
Call: 0200 - 810 010 or 1-800-722-9377 or +46812045900
Media Gallery
Features
IVUS helps with disease assessment
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
Helps with intervention decisions
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps confirm treatment results
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Real-time lesion assessment in the cath lab
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
ChromaFlo stent apposition assessment
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS helps with disease assessment
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
IVUS imaging helps physicians assess disease markers, including plaque burden percentage, lesion location and morphology, calcium volume, and the presence of thrombus. It also provides analysis of crucial parameters—like luminal cross-sectional measurements—and aids in disease diagnosis.
Helps with intervention decisions
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps with intervention decisions
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Not only does IVUS provide real-time diagnostic imaging for peripheral artery disease, it may also guide clinicians to the correct angioplasty technique for the patient’s individual needs, assess intervention effectiveness, and assist in endovascular device delivery. The imaging modality also helps clinicians decide the size of the device needed for the best outcome.
Helps confirm treatment results
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Helps confirm treatment results
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
IVUS imaging helps to confirm treatment results, including the completeness of treatment, the apposition and expansion of stent placement, and whether or not the patient requires a thrombolytic drip. ChromaFlo imaging, for example, can be used to show evidence of stent apposition by illustrating the absence of flow.
Real-time lesion assessment in the cath lab
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
Real-time lesion assessment in the cath lab
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
VH IVUS imaging provides a colorized tissue map of plaque composition with automated lumen and vessel measurements. VH IVUS technology uses advanced, proprietary spectral analysis techniques to classify plaque into 4 tissue types with 93-97% accuracy. *, ²
ChromaFlo stent apposition assessment
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo stent apposition assessment
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
ChromaFlo highlights blood flow red for easy assessment of stent apposition, lumen size, and more. Appropriate for peripheral and coronary vessels, including left main, bifurcations, superficial femoral artery, and iliac. It is designed to make lumen size and stent apposition instantly recognizable and helps identify branches, dissections, and plaque in bifurcations.
2. Nair A, Margolis M, Kuban B, Vince D. Automated Coronary Plaque Characterisation with Intravascular Ultrasound Backscatter: Ex Vivo Validation. EuroIntervention. 2007; 3: 113-120
* Safety and effectiveness of VH IVUS for use in the characterization of vascular lesions and tissue types has not been established
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Philips reserves the right to change product specifications without prior notification.
Genom att klicka på länken kommer du att lämna den officiella Philips Electronics Ltd. ("Philips") webbplats. Alla länkar till tredje parts webbplatser som kan visas på denna webbplats tillhandahålls endast för din bekvämlighet och representerar inte på något sätt någon anknytning till eller stöd för informationen som tillhandahålls på dessa länkade webbplatser. Philips lämnar inga utfästelser eller garantier av något slag med avseende på tredje parts webbplatser eller informationen däri.
